Literature DB >> 2668503

Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.

J P Hieble1, J G Duesler, R N Daly.   

Abstract

Although neuropeptide Y (NPY) is not a potent vasoconstrictor in many vascular beds, nanomolar concentrations of this peptide can potentiate the response of isolated blood vessels to sympathetic stimulation or exogenous vasoconstrictors. In the isolated perfused rabbit ear artery, NPY produces a concentration-related potentiation of the response to field stimulation. The potency of NPY in inducing potentiation of nerve-mediated vasoconstriction was not dependent on whether the NPY was administered intra- or extraluminally. In these perfused vessels the endothelium was intact. Similar potentiation of the response to field stimulation is also observed in superfused ring segments of rabbit ear artery, provided that the endothelium was not damaged mechanically. The response to field stimulation in the rabbit ear artery is mediated by the alpha-1 adrenoceptor; in contrast, stimulation induced contraction in the canine saphenous vein results from the activation of vascular alpha-2-adrenoceptors. Despite this difference, the effect of NPY in ring segments of canine saphenous vein was similar to that observed in the ear artery. NPY also produced an endothelium-dependent potentiation of the constrictor response to exogenous norepinephrine in superfused segments of both ear artery and saphenous vein. Although the NPY-induced potentiation of stimulation-induced vasoconstriction was not inhibited by indomethacin, suggesting that an arachidonic acid metabolite is not involved, the release of another endothelial-derived vasoconstrictor substance, as yet unidentified, by NPY may explain its ability to potentiate the responses to both nerve stimulation and a variety of exogenous vasoconstrictors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668503

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  alpha(2)-adrenoceptor and NPY receptor-mediated contractions of porcine isolated blood vessels: evidence for involvement of the vascular endothelium.

Authors:  R E Roberts; D A Kendall; V G Wilson
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail.

Authors:  M R MacLean; J C McGrath
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

3.  Effect of neuropeptide Y on alpha 2-adrenoceptor-mediated cardiovascular responses in the pithed rat.

Authors:  E Vila; I M Macrae
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

4.  Plasma neuropeptide Y in the symptomatic limb of patients with causalgic pain.

Authors:  P D Drummond; P M Finch; L Edvinsson; P J Goadsby
Journal:  Clin Auton Res       Date:  1994-06       Impact factor: 4.435

5.  Neuropeptide Y potentiates calcium-channel currents in single vascular smooth muscle cells.

Authors:  Z Xiong; B J Bolzon; D W Cheung
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

6.  Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: non-uniform pattern of vascular reactivity.

Authors:  M S Dietrich; M Fretschner; R Nobiling; P B Persson; M Steinhausen
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

7.  Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endothelium.

Authors:  D Prieto; S Benedito; U Simonsen; N C Nyborg
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.